Westbourne Investments Inc. Buys Shares of 4,835 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Westbourne Investments Inc. acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,835 shares of the medical equipment provider's stock, valued at approximately $2,524,000. Intuitive Surgical makes up about 1.5% of Westbourne Investments Inc.'s investment portfolio, making the stock its 17th largest holding.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Howard Capital Management Group LLC increased its position in shares of Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after buying an additional 92 shares in the last quarter. Principal Financial Group Inc. grew its stake in Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock valued at $295,938,000 after acquiring an additional 9,194 shares during the period. World Investment Advisors LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth $228,000. Arvest Bank Trust Division acquired a new position in Intuitive Surgical during the third quarter worth $260,000. Finally, Wilmington Savings Fund Society FSB lifted its holdings in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insiders Place Their Bets

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock valued at $17,229,143 over the last quarter. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Trading Down 0.4 %

NASDAQ:ISRG traded down $2.38 during mid-day trading on Tuesday, hitting $529.44. The stock had a trading volume of 492,411 shares, compared to its average volume of 1,619,980. Intuitive Surgical, Inc. has a twelve month low of $379.67 and a twelve month high of $616.00. The company has a market capitalization of $189.76 billion, a PE ratio of 82.61, a PEG ratio of 5.85 and a beta of 1.70. The stock has a 50-day simple moving average of $503.33 and a two-hundred day simple moving average of $534.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company posted $1.50 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on ISRG shares. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Royal Bank of Canada cut their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Barclays decreased their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.